Adverse Drug Reactions in Hospitals: A Narrative Review

被引:67
作者
Davies, Emma C. [1 ,3 ]
Green, Christophe F. [2 ]
Mottram, David R. [3 ]
Pirmohamed, Munir [1 ,4 ]
机构
[1] Royal Liverpool Univ Hosp Trust, Liverpool L7 8XP, Merseyside, England
[2] Countess Chester NHS Fdn Trust, Chester CH2 1UL, Cheshire, England
[3] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England
[4] Univ Liverpool, Dept Pharmacol & Therapeut, Ashton St, Liverpool L69 3GE, Merseyside, England
关键词
Adverse drug reactions; hospitals;
D O I
10.2174/157488607779315507
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The serious nature of adverse drug reactions (ADRs) has been highlighted in a number of instances over the last forty years, the most recent of these being the occurrence of serious thrombotic events with the use of COX-2 inhibitors. ADRs are estimated to be between the 4th and 6th leading cause of death in the USA, with fatal ADRs occurring in 0.32% of patients. A recent UK study showed that 6.5% of hospital admissions were related to ADRs. ADRs can therefore be regarded as a significant public health and economic problem. There is an urgent need to develop better preventive strategies to reduce the burden of ADRs. Because ADRs can affect any bodily system, can have many different clinical presentations, and are of widely variable severity, prevention will not be easy and will have to be multifactorial in its approach. This paper reviews the epidemiology of ADRs in hospitals and evaluates the research that has been undertaken to date to prevent ADRs.
引用
收藏
页码:79 / 87
页数:9
相关论文
共 113 条
[71]  
MCDONNELL PJ, 2004, HOSP PHARM, V39, P648
[72]   Pharmacogenetics and adverse drug reactions [J].
Meyer, UA .
LANCET, 2000, 356 (9242) :1667-1671
[73]   Frequency and cost of serious adverse drug reactions in a department of general medicine [J].
Moore, N ;
Lecointre, D ;
Noblet, C ;
Mabille, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (03) :301-308
[74]   A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[75]  
Nguyen Julia K, 2006, Am J Geriatr Pharmacother, V4, P36, DOI 10.1016/j.amjopharm.2006.03.002
[76]  
OGILVIE RI, 1967, CAN MED ASSOC J, V97, P1450
[77]   Depression and adverse drug reactions among hospitalized older adults [J].
Onder, G ;
Penninx, BWJH ;
Landi, F ;
Atkinson, H ;
Cesari, M ;
Bernabei, R ;
Pahor, M .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (03) :301-305
[78]   Adverse drug reactions and cognitive function among hospitalized older adults [J].
Onder, G ;
Gambassi, G ;
Scales, CJ ;
Cesari, M ;
Della Vedova, C ;
Landi, F ;
Bernabei, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (05) :371-377
[79]   FACTORS ASSOCIATED WITH PREVENTABLE ADVERSE DRUG-REACTIONS [J].
PEARSON, TF ;
PITTMAN, DG ;
LONGLEY, JM ;
GRAPES, ZT ;
VIGLIOTTI, DJ ;
MULLIS, SR .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (18) :2268-2272
[80]   Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes [J].
Pestotnik, SL ;
Classen, DC ;
Evans, RS ;
Burke, JP .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (10) :884-+